Editorial Board
Editor in Chief
Aaron Lisberg,Ph.D.
Professor,
Ronald Reagan UCLA Medical Center UCLA Medical Center, Santa Monica, California, USA.
Phone: 310-829-5471
Editorial Board Member's
Mariana bonjiorno martins
Editorial Board Member
Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, São Paulo, Brazil,+55 19 992493174
Interests: Cancer molecular genetics, tumor biology and signaling pathways, cancer therapeutics and drug response, molecular biomarkers in oncology, human and medical genetics, translational cancer research
Interests: Cancer molecular genetics, tumor biology and signaling pathways, cancer therapeutics and drug response, molecular biomarkers in oncology, human and medical genetics, translational cancer research
Eda Alemdar
Editorial Board Member
Goce Delchev University, Stip-Macedonia, North Macedonia,+905424050534
Interests: Dr. Eda Alemdar’s research interest includes cataract treatment, sinusitis remedy, the importance of biological clock and biological rhythm in the treatment of diseases, external factors that direct the Biological Clock and role in treatment of disease, and blood and body health.
Interests: Dr. Eda Alemdar’s research interest includes cataract treatment, sinusitis remedy, the importance of biological clock and biological rhythm in the treatment of diseases, external factors that direct the Biological Clock and role in treatment of disease, and blood and body health.
BaoFa Yu
Editorial Board Member
TaiMei Baofa Cancer Hospital, Dongping, 271500, Shandong Province, China.,858-287-8878
Interests: chemoimmunotherapy, chemo-hapten technology, intratumoral chemotherapy, cancer immunotherapy, solid tumor treatment, non-small cell lung cancer, liver carcinoma, late-stage cancer management, anti-cancer drug development, translational oncology
Interests: chemoimmunotherapy, chemo-hapten technology, intratumoral chemotherapy, cancer immunotherapy, solid tumor treatment, non-small cell lung cancer, liver carcinoma, late-stage cancer management, anti-cancer drug development, translational oncology
Domenico Galetta
Editorial Board Member
Division of Thoracic Surgery, European Institute of Oncology, , Milan, Italy.,+39 02 5748 9801
Interests: Thoracic surgical oncology, lung cancer management, pleural diseases, mediastinal disorders, chest wall tumors, diabetes mellitus and its complications, diabetic foot, diabetic neuropathy, vascular diseases, metabolic syndrome, obesity, obstructive sleep apnea syndrome (OSAS), medical and scientific writing.
Interests: Thoracic surgical oncology, lung cancer management, pleural diseases, mediastinal disorders, chest wall tumors, diabetes mellitus and its complications, diabetic foot, diabetic neuropathy, vascular diseases, metabolic syndrome, obesity, obstructive sleep apnea syndrome (OSAS), medical and scientific writing.
Bingling Dai
Editorial Board Member
School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an 710061, Shaanxi Province, China.,+8613474101461
Interests: Tumor cell biology, cancer mechanisms, cell culture systems, drug screening and analysis, molecular oncology, cancer progression pathways, experimental pharmacology, anticancer drug development.
Interests: Tumor cell biology, cancer mechanisms, cell culture systems, drug screening and analysis, molecular oncology, cancer progression pathways, experimental pharmacology, anticancer drug development.
Luo Huacheng
Editorial Board Member
USA,(+1) 352-231-8934
Interests: The overall goal of my research is to investigate the epigenetic mechanisms that are involved in the normal and malignant hematopoiesis to further delineate how these networks are regulated in acute myeloid leukemia (AML). I have also a broad background in biochemistry and molecular biology with specific training and expertise on applying molecular biological and bioinformatics technologies to studying the mechanism of chromatin organization and remodeling regulation in human normal and malignant hematopoiesis. One of my research projects published in Blood, I have found one of critical CTCF boundary between HOXA7/HOXA9 genes (CBS7/9) remodels chromatin domain and induces aberrant HOX gene expression in acute myeloid leukemia. In order to figure out whether this critical boundary CBS7/9 mediated chromatin structure organization for leukemogenesis in vitro and in vivo, 4C-seq, ATAC-seq and HiC-seq have been applied to clarify this mechanism. As an assistant professor in Penn State University, I are focused on the bioinformatics analysis and have a good collaboration with others to analyze Next Generation Sequencing data to figure out the role of HOX associated lncRNAs (long non-coding RNAs) in leukemogenesis. HOTTIP as one of critical lncRNAs in HOXA loci, which has a coordinate function with CTCF boundary to control the HOXA chromatin structure organization and HOXA genes transcription, and lots of next generation sequence (NGS) datasets from patient tumor samples and cancer cell lines, such as ATAC-seq, RNA-seq, 4C-seq, ChIP-seq and Hi-C-seq, have been used to elucidate this hypothesis. Thus, combination of molecular biological and bioinformatics technologies to investigate the mechanism of human normal and malignant hematopoiesis will well support in my future research projects
Interests: The overall goal of my research is to investigate the epigenetic mechanisms that are involved in the normal and malignant hematopoiesis to further delineate how these networks are regulated in acute myeloid leukemia (AML). I have also a broad background in biochemistry and molecular biology with specific training and expertise on applying molecular biological and bioinformatics technologies to studying the mechanism of chromatin organization and remodeling regulation in human normal and malignant hematopoiesis. One of my research projects published in Blood, I have found one of critical CTCF boundary between HOXA7/HOXA9 genes (CBS7/9) remodels chromatin domain and induces aberrant HOX gene expression in acute myeloid leukemia. In order to figure out whether this critical boundary CBS7/9 mediated chromatin structure organization for leukemogenesis in vitro and in vivo, 4C-seq, ATAC-seq and HiC-seq have been applied to clarify this mechanism. As an assistant professor in Penn State University, I are focused on the bioinformatics analysis and have a good collaboration with others to analyze Next Generation Sequencing data to figure out the role of HOX associated lncRNAs (long non-coding RNAs) in leukemogenesis. HOTTIP as one of critical lncRNAs in HOXA loci, which has a coordinate function with CTCF boundary to control the HOXA chromatin structure organization and HOXA genes transcription, and lots of next generation sequence (NGS) datasets from patient tumor samples and cancer cell lines, such as ATAC-seq, RNA-seq, 4C-seq, ChIP-seq and Hi-C-seq, have been used to elucidate this hypothesis. Thus, combination of molecular biological and bioinformatics technologies to investigate the mechanism of human normal and malignant hematopoiesis will well support in my future research projects
Adrian Pablo Hunis
Editorial Board Member
Department of Medicine, Universidad de Buenos Aires (UBA), Argentina.,5491149144515
Interests: Clinical oncology, cancer research, and medical oncology.
Interests: Clinical oncology, cancer research, and medical oncology.
Frank Griesinger
Editorial Board Member
Department of Hematology and Oncology University Department Internal Medicine-Oncology Pius-Hospital Oldenburg University of Oldenburg, Germany,+ 49 (441) 229 1610
Interests: Dr. Griesinger has further researched interests in the treatment of molecular subgroups of lung cancer. He is currently very involved in introducing molecular stratified treatments in the lung cancer in the Germany and is the 1st author of guidelines of the German Society of Hematology and Oncology for the treatment of Non-Small-Lung Cancer.
Interests: Dr. Griesinger has further researched interests in the treatment of molecular subgroups of lung cancer. He is currently very involved in introducing molecular stratified treatments in the lung cancer in the Germany and is the 1st author of guidelines of the German Society of Hematology and Oncology for the treatment of Non-Small-Lung Cancer.
Kazumi Fujioka
Editorial Board Member
Nihon University School of Medicine, Tokyo, Japan,-
Interests: Radiology, ultrasound medicine, gastroenterology, carcinogenesis, vascular medicine, dermatological imaging
Interests: Radiology, ultrasound medicine, gastroenterology, carcinogenesis, vascular medicine, dermatological imaging
Janusz Andrzej kocik
Editorial Board Member
National Centre for Nuclear Research, Świerk (Otwock region), 05-400 Otwock, Poland,+48 609 608 303
Interests: Haematology, Oncology, Internal medicine, Nuclear medicine applications in clinical research, Translational cancer research, Disease diagnostics and biomarker studies
Interests: Haematology, Oncology, Internal medicine, Nuclear medicine applications in clinical research, Translational cancer research, Disease diagnostics and biomarker studies
Daniela Capdepon
Editorial Board Member
Cancer Center Campana Oncology and Oncohematology Researcher, Argentina.,+549 348961 8997
Interests: Dr. Capdepon’s research focuses on clinical oncology and oncohematology, including solid tumors and hematologic malignancies. She has a strong interest in chemotherapy, leukemia (ALL, CLL), lymphomas, and palliative care approaches for cancer pain management.
Interests: Dr. Capdepon’s research focuses on clinical oncology and oncohematology, including solid tumors and hematologic malignancies. She has a strong interest in chemotherapy, leukemia (ALL, CLL), lymphomas, and palliative care approaches for cancer pain management.
Liu Liang
Editorial Board Member
Department of Oncology, Third Affiliated Hospital of Guizhou Medical University, Guizhou Province, China.,,
Interests: Solid Tumor Treatment Strategies, Cancer Gene Detection, Breast Cancer Micrometastasis, Molecular Oncology, Clinical Oncology, Translational Research, Cancer Diagnostics, Therapeutic Outcomes
Interests: Solid Tumor Treatment Strategies, Cancer Gene Detection, Breast Cancer Micrometastasis, Molecular Oncology, Clinical Oncology, Translational Research, Cancer Diagnostics, Therapeutic Outcomes
Hilal Arnouk
Editorial Board Member
Department of Pathology at Midwestern University, USA.,00
Interests: Hilal Arnouk’s research focuses on Cancer Immunotherapy, Precision Medicine, and Pathology. His work emphasizes biomarker discovery and translational approaches to improve cancer diagnosis and treatment outcomes.
Interests: Hilal Arnouk’s research focuses on Cancer Immunotherapy, Precision Medicine, and Pathology. His work emphasizes biomarker discovery and translational approaches to improve cancer diagnosis and treatment outcomes.
Aida Santaolalla Revenga
Editorial Board Member
King’s College London, School of Cancer & Pharmaceutical Sciences, Guy’s Campus, Great Maze Pond, London SE1 1UL, United Kingdom.,2147483647
Interests: Oncology and translational cancer research with focus on cancer systems biology, molecular epidemiology, and cancer risk stratification.
Interests: Oncology and translational cancer research with focus on cancer systems biology, molecular epidemiology, and cancer risk stratification.
Sorush Niknamian
Editorial Board Member
Wisconsin Avenue, NW Washington, DC 20016 USA,+44(793)7058125
Interests: Clinical oncology, cancer biology, molecular biology, infectious diseases, and biomedical sciences with a focus on multidisciplinary and translational research.
Interests: Clinical oncology, cancer biology, molecular biology, infectious diseases, and biomedical sciences with a focus on multidisciplinary and translational research.
Vera Marta Reolon
Editorial Board Member
Psychology Federal University of Rio Grande do Sul, Brazil,-
Interests: Dr. Vera Marta Reolon’s research interests focus on the field of psychology, particularly in understanding human behavior, mental processes, and academic studies related to psychological sciences. Her work contributes to foundational and applied aspects of psychology in educational and research settings.
Interests: Dr. Vera Marta Reolon’s research interests focus on the field of psychology, particularly in understanding human behavior, mental processes, and academic studies related to psychological sciences. Her work contributes to foundational and applied aspects of psychology in educational and research settings.
Yusheng Zhu
Editorial Board Member
Penn State Health Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA,(717)531-5123
Interests: Clinical chemistry, toxicology, and pharmacogenetics, with emphasis on mass spectrometry and proteomics in disease diagnosis and personalized medicine.
Interests: Clinical chemistry, toxicology, and pharmacogenetics, with emphasis on mass spectrometry and proteomics in disease diagnosis and personalized medicine.
SITHEMBILE NGIDI
Editorial Board Member
CLINICAL & RADIATION ONCOLOGIST LENMED AHMED KATHRADA PRIVATE HOSPITAL, South African,011 2132250
Interests: Research Interesting on Cancer, Oncology and Public Health
Interests: Research Interesting on Cancer, Oncology and Public Health
Ricardo Bonfim Silva
Editorial Board Member
University of São Paulo Brazil.,55 16 3315-3305/4990
Interests: Molecular and cellular Oncology, Tumor Microenvironment, Long noncoding RNAs, Mesenquimal Stem cells, Human and Medical Genetics, and Molecular and Cell Biology.
Interests: Molecular and cellular Oncology, Tumor Microenvironment, Long noncoding RNAs, Mesenquimal Stem cells, Human and Medical Genetics, and Molecular and Cell Biology.
Nicola Montano
Editorial Board Member
Institute of Neurosurgery Gemelli University Hospital, Catholic University, Rome, Italy,
Interests: Neuro-oncology spine surgery functional neurosurgery
Interests: Neuro-oncology spine surgery functional neurosurgery
Thiagarajan Venkatesan
Editorial Board Member
Rumbaugh Goodwin Institute for Cancer Research, Nova Southeastern University, Florida, USA.,,
Interests: My research interests are focused on: Prognostic and diagnostic markers and novel therapeutic targets for human cancers, development of new therapeutic molecules against cancer, cloning, expression and purification of new biologics, testing the efficacy of small molecules, natural products and therapeutic molecules against various cancers, analyzing the pathway specific gene expression profile.
Interests: My research interests are focused on: Prognostic and diagnostic markers and novel therapeutic targets for human cancers, development of new therapeutic molecules against cancer, cloning, expression and purification of new biologics, testing the efficacy of small molecules, natural products and therapeutic molecules against various cancers, analyzing the pathway specific gene expression profile.
Alain L Fymat
Editorial Board Member
International Institute of Medicine and Science, Rancho Mirage, California, USA.,00
Interests: Neurodegenerative Diseases, Alzheimer’s Disease, Parkinson’s Disease, Glioblastoma, Oncology, Epigenetics, Nanomedicine, Translational Medicine, Critical Care Medicine, Radiation Medicine
Interests: Neurodegenerative Diseases, Alzheimer’s Disease, Parkinson’s Disease, Glioblastoma, Oncology, Epigenetics, Nanomedicine, Translational Medicine, Critical Care Medicine, Radiation Medicine
Takuma Hayashi
Editorial Board Member
Department of Cancer, Shinshu University, Japan.,090-1996-2144
Interests: Molecular approach of tumorigenesis of uterine leiomyosarcoma and Ovarian cancer
Interests: Molecular approach of tumorigenesis of uterine leiomyosarcoma and Ovarian cancer
Wang Lin
Editorial Board Member
NYU Grossman School of Medicine, 550 First Avenue, New York, NY 10016, USA,00
Interests: Dr. Wang Lin focuses on oncology research, particularly gastric cancer, melanoma, and treatment-resistant cancers. His work explores tumor progression, metastasis mechanisms, and immunotherapy resistance, including PD-1 checkpoint blockade in cancer treatment.
Interests: Dr. Wang Lin focuses on oncology research, particularly gastric cancer, melanoma, and treatment-resistant cancers. His work explores tumor progression, metastasis mechanisms, and immunotherapy resistance, including PD-1 checkpoint blockade in cancer treatment.
Selma Sakhri
Editorial Board Member
Maherzy School of Medicine, Algeria,+213 771250007
Interests: Endometrial cancer Cancer and pregnancy Clinical Trial Principle of chemotherapy
Interests: Endometrial cancer Cancer and pregnancy Clinical Trial Principle of chemotherapy
Valerii A Voinov
Editorial Board Member
Department of Pulmonology clinic, I.P. Pavlov’s St. Petersburg State Medical University, Russia.,+7-812-338-78-07
Interests: Therapeutic apheresis in rheumatology, allergy, neurology, pulmonology, nephrology, diabetes, oncology, transplantology, obstetrics, neonatology, anti-aging medicine; resuscitation & critical care.
Interests: Therapeutic apheresis in rheumatology, allergy, neurology, pulmonology, nephrology, diabetes, oncology, transplantology, obstetrics, neonatology, anti-aging medicine; resuscitation & critical care.
Sneh Manishi Toprani
Editorial Board Member
Harvard T.H. Chan School of Public Health,677 Huntington Avenue, Boston, MA 02115, USA.,00
Interests: Dr. Sneh Manishi Toprani focuses on DNA damage and repair mechanisms in human cells, particularly under radiation and nanoparticle exposure. Her work integrates molecular biology techniques to study gene expression, cell signaling, and cancer biology, aiming to understand cellular responses to environmental stress.
Interests: Dr. Sneh Manishi Toprani focuses on DNA damage and repair mechanisms in human cells, particularly under radiation and nanoparticle exposure. Her work integrates molecular biology techniques to study gene expression, cell signaling, and cancer biology, aiming to understand cellular responses to environmental stress.
Michel Leclerc
Editorial Board Member
Division de Biologie/Biochimie, Université d'Orléans, France.,0238410209
Interests: Immunology and the immunology of infectious diseases, with a focus on antibodies, inflammation, cell biology, and genomics. Methodological expertise includes electrophoresis, gel electrophoresis, cell culture, and flow cytometry.
Interests: Immunology and the immunology of infectious diseases, with a focus on antibodies, inflammation, cell biology, and genomics. Methodological expertise includes electrophoresis, gel electrophoresis, cell culture, and flow cytometry.
Minghua Wu
Editorial Board Member
Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, China.,86-13874852883
Interests: Cancer biology, molecular biology, cell biology, gene expression, tumor biology, signal transduction, oncogenes, tumor suppressor genes, cancer genetics, epigenetics, apoptosis, biomarkers.
Interests: Cancer biology, molecular biology, cell biology, gene expression, tumor biology, signal transduction, oncogenes, tumor suppressor genes, cancer genetics, epigenetics, apoptosis, biomarkers.
Rolf Bambauer
Editorial Board Member
Formerly, Private Institute for Blood Purification, University of Saarland, 66424 Homburg, Germany.,0049/6841/68500
Interests: Dr. Bambauer’s research focuses on blood purification technologies, immunology, inflammation, and clinical epidemiology. His work integrates nephrology and extracorporeal therapies to improve patient outcomes in chronic and critical care settings.
Interests: Dr. Bambauer’s research focuses on blood purification technologies, immunology, inflammation, and clinical epidemiology. His work integrates nephrology and extracorporeal therapies to improve patient outcomes in chronic and critical care settings.
Prashanth Hari Dass
Editorial Board Member
Medical Oncologist, Rotorua Hospital, 1111 Haupapa Street, Rotorua 3010, New Zealand.,00
Interests: Focuses on medical oncology, clinical oncology, cancer diagnostics, metastasis, prognosis, and cancer immunology, with an emphasis on improving access to investigational cancer treatments.
Interests: Focuses on medical oncology, clinical oncology, cancer diagnostics, metastasis, prognosis, and cancer immunology, with an emphasis on improving access to investigational cancer treatments.
Number Place
